Stefan G, Zugravu A, Stancu S. Intravenous cyclophosphamide as an alternative to the oral cyclophosphamide modified Ponticelli regimen for high-risk PLA2R-positive membranous nephropathy. J Nephrol 2022 Aug 12. pii: 10.1007/s40620-022-01426.
PMID: 35960429